Vor Biopharma Inc. (VOR)
NASDAQ: VOR
· Real-Time Price · USD
2.13
0.15 (7.58%)
At close: Aug 15, 2025, 3:59 PM
2.12
-0.24%
After-hours: Aug 15, 2025, 07:58 PM EDT
Vor Biopharma Balance Sheet Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Cash & Equivalents | 190.57M | 50.05M | 81.95M | 52.8M | 76.08M | 44.96M | 31.36M | 45.03M | 32.21M | 42.45M | 57.71M | 60.83M | 62.95M | 90.04M | 119.8M | 143.03M | 169.52M | 262.57M |
Short-Term Investments | 9.99M | 9.99M | 9.98M | 10.01M | 9.86M | 62.52M | 105.81M | 115.07M | 154.69M | 167.75M | 172.54M | 75.24M | 88.14M | 91.58M | 87.67M | 82.93M | 75.12M | n/a |
Long-Term Investments | n/a | n/a | n/a | 2.41M | 2.41M | 2.41M | 2.41M | n/a | 2.41M | 2.41M | 2.41M | 2.41M | 2.41M | 2.41M | 87.67M | 2.41M | 1.56M | 1.56M |
Other Long-Term Assets | 420K | 4.78M | 14.92M | 2.51M | 3.06M | 4.82M | 4.81M | 6.5M | 3.27M | 2.79M | 2.92M | 2.88M | 2.38M | 8.19M | -82M | 2.14M | 2.11M | 2.58M |
Receivables | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Inventory | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Current Assets | 4.36M | 297K | 380K | 285K | 272K | 507K | 475K | 667K | 539K | 459K | 2.34M | 1.77M | 2.29M | 2.21M | 2.09M | 749K | 65K | 92K |
Total Current Assets | 204.93M | 64.85M | 96.51M | 67.3M | 90.26M | 111.82M | 140.8M | 164.44M | 191.39M | 216.9M | 236.95M | 142.73M | 158.84M | 190.3M | 214.4M | 232.07M | 249.26M | 266.26M |
Property-Plant & Equipment | 24K | 39.68M | 41.59M | 43.77M | 45.86M | 47.98M | 50.1M | 52.09M | 53.91M | 55.43M | 57.08M | 58.35M | 60.97M | 33.36M | 22.52M | 22.01M | 22.21M | 22.53M |
Goodwill & Intangibles | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Total Long-Term Assets | 444K | 44.47M | 56.51M | 48.7M | 51.33M | 55.21M | 69.03M | 58.59M | 59.59M | 60.63M | 62.42M | 63.64M | 65.77M | 43.97M | 28.19M | 26.56M | 25.88M | 26.67M |
Total Assets | 205.37M | 109.31M | 142.89M | 115.99M | 141.59M | 167.03M | 209.83M | 223.02M | 250.99M | 277.53M | 299.37M | 206.37M | 224.62M | 234.27M | 242.59M | 258.63M | 275.14M | 292.94M |
Account Payables | 669K | 3.73M | 1.5M | 1.32M | 2.01M | 2.33M | 815K | 1.31M | 1.65M | 3.22M | 1.77M | 824K | 1.27M | 1.25M | 1.54M | 1.96M | 2.37M | 2.41M |
Deferred Revenue | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 7.11M | n/a | n/a | n/a | n/a | n/a | 6.33M | 5.68M | 4.29M | 4.39M |
Short-Term Debt | n/a | n/a | n/a | n/a | n/a | 3.96M | 3.83M | 3.74M | 3.69M | 3.71M | n/a | 3.76M | 4.43M | 7.28M | 1.84M | 1.15M | 1.16M | 1.16M |
Other Current Liabilities | 45.35M | 2.15M | 6.21M | 4.15M | 4.27M | 1.07M | 2.46M | 945K | 564K | 361K | 3.67M | -319K | -473K | 42K | 3.39M | 3.12M | 1.63M | 2.32M |
Total Current Liabilities | 58.77M | 16.73M | 18.61M | 14.35M | 13.8M | 13.21M | 15.57M | 15.39M | 12.72M | 12.58M | 13.12M | 11.1M | 12.26M | 18.14M | 10.15M | 9.21M | 8.3M | 8.63M |
Long-Term Debt | n/a | n/a | n/a | n/a | n/a | n/a | 31.83M | n/a | 33.82M | 34.74M | n/a | 36.54M | 37.38M | 21.68M | 16.17M | 16.46M | 16.73M | 17.12M |
Other Long-Term Liabilities | 1.65B | n/a | n/a | n/a | n/a | n/a | -31.83M | n/a | -33.82M | -34.74M | n/a | -36.54M | -37.38M | -21.68M | -16.17M | -16.46M | -16.73M | -17.12M |
Total Long-Term Liabilities | 1.65B | 26.52M | 27.61M | 28.69M | 29.71M | 30.78M | 43.53M | 32.85M | 33.82M | 34.74M | 35.64M | 36.54M | 37.38M | 21.68M | 16.17M | 16.46M | 16.73M | 17.12M |
Total Liabilities | 1.71B | 43.24M | 46.23M | 43.04M | 43.51M | 43.99M | 59.1M | 48.24M | 46.54M | 47.32M | 48.76M | 47.64M | 49.64M | 39.82M | 26.33M | 25.68M | 25.04M | 25.75M |
Total Debt | n/a | 30.78M | 31.83M | 32.85M | 33.82M | 34.74M | 35.66M | 36.6M | 37.51M | 38.45M | 38.91M | 40.29M | 41.81M | 28.96M | 18.01M | 17.61M | 17.89M | 18.28M |
Common Stock | 13K | 13K | 13K | 7K | 7K | 7K | 7K | 7K | 7K | 7K | 7K | 4K | 4K | 4K | 4K | 4K | 4K | 4K |
Retained Earnings | -2.06B | -489.48M | -456.99M | -426.28M | -398.72M | -370.88M | -340.08M | -313.82M | -280.63M | -250.65M | -222.22M | -198.31M | -174.52M | -152.86M | -130.12M | -111.87M | -93.32M | -74.95M |
Comprehensive Income | 14K | 23K | 22K | 68K | -70K | -87K | -77K | -280K | -436K | -174K | -770K | -1.18M | -1.33M | -1.07M | n/a | -258.63M | -275.14M | -292.94M |
Shareholders Equity | -1.51B | 66.07M | 96.66M | 72.95M | 98.08M | 123.03M | 150.72M | 174.78M | 204.45M | 230.22M | 250.61M | 158.73M | 174.97M | 194.45M | 216.26M | 232.96M | 250.11M | 267.19M |
Total Investments | 9.99M | 9.99M | 9.98M | 10.01M | 12.28M | 64.93M | 108.23M | 115.07M | 154.69M | 167.75M | 172.54M | 75.24M | 88.14M | 91.58M | 87.67M | 82.93M | 75.12M | 1.56M |